Authors: Mylari, BL Oates, PJ Beebe, DA Brackett, NS Coutcher, JB Dina, MS Zembrowski, WJ

Citation: Bl. Mylari et al., Sorbitol dehydrogenase inhibitors (SDIs): A new potent, enantiomeric SDI, 4-[2-1R-hydroxy-ethyl)-pyrimidin-4-yl]-piperazine-1-sulfonic acid dimethylamide, J MED CHEM, 44(17), 2001, pp. 2695-2700

Authors: Tracey, WR Magee, WP Ellery, CA MacAndrew, JT Smith, AH Knight, DR Oates, PJ

Citation: Wr. Tracey et al., Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury, AM J P-HEAR, 279(4), 2000, pp. H1447-H1452

Authors: Nishikawa, T Edelstein, D Du, XL Yamagishi, S Matsumura, T Kaneda, Y Yorek, MA Beebe, D Oates, PJ Hammes, HP Giardino, I Brownlee, M

Citation: T. Nishikawa et al., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, NATURE, 404(6779), 2000, pp. 787-790

Authors: Siegel, TW Smith, SR Ellery, CA Williamson, JR Oates, PJ

Citation: Tw. Siegel et al., An enzymatic fluorometric assay for fructose, ANALYT BIOC, 280(2), 2000, pp. 329-331

Authors: Ramasamy, R Liu, H Oates, PJ Schaefer, S

Citation: R. Ramasamy et al., Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor Zopolrestat, CARDIO RES, 42(1), 1999, pp. 130-139